| Parameters . | HR (95% Cl) . | P-value . |
|---|---|---|
| Model 1 | ||
| Euroscore II, per 1% increase | 0.991 (0.948–1.037) | 0.706 |
| Late vs. early TAVI | 0.503 (0.344–0.736) | <0.001 |
| Staging at baseline (per 1 stage increase) | 1.316 (1.097–1.577) | 0.003 |
| Model 2 | ||
| Euroscore II, per 1% increase | 1.033 (0.981–1.089) | 0.218 |
| Late vs. early TAVI | 0.574 (0.336–0.981) | 0.042 |
| Staging at baseline (per 1 stage increase) | 0.948 (0.717–1.254) | 0.710 |
| Staging at 6 months (per 1 stage increase) | 1.368 (1.002–1.867) | 0.048 |
| Model 3 | ||
| Euroscore II, per 1% increase | 1.033 (0.981–1.089) | 0.217 |
| Late vs. early TAVI | 0.581 (0.340–0.994) | 0.047 |
| Staging at baseline (per 1 stage increase) | 1.391 (1.024–1.890) | 0.035 |
| Staging evolution at 6 months | ||
| Improved | — | 0.017 |
| Stabilized | 1.838 (0.993–3.401) | 0.053 |
| Worsened | 3.729 (1.494–9.305) | 0.005 |
| Parameters . | HR (95% Cl) . | P-value . |
|---|---|---|
| Model 1 | ||
| Euroscore II, per 1% increase | 0.991 (0.948–1.037) | 0.706 |
| Late vs. early TAVI | 0.503 (0.344–0.736) | <0.001 |
| Staging at baseline (per 1 stage increase) | 1.316 (1.097–1.577) | 0.003 |
| Model 2 | ||
| Euroscore II, per 1% increase | 1.033 (0.981–1.089) | 0.218 |
| Late vs. early TAVI | 0.574 (0.336–0.981) | 0.042 |
| Staging at baseline (per 1 stage increase) | 0.948 (0.717–1.254) | 0.710 |
| Staging at 6 months (per 1 stage increase) | 1.368 (1.002–1.867) | 0.048 |
| Model 3 | ||
| Euroscore II, per 1% increase | 1.033 (0.981–1.089) | 0.217 |
| Late vs. early TAVI | 0.581 (0.340–0.994) | 0.047 |
| Staging at baseline (per 1 stage increase) | 1.391 (1.024–1.890) | 0.035 |
| Staging evolution at 6 months | ||
| Improved | — | 0.017 |
| Stabilized | 1.838 (0.993–3.401) | 0.053 |
| Worsened | 3.729 (1.494–9.305) | 0.005 |
Values are HR (95% CI). Bold values represent significant P-values (<0.05).
CI, confidence interval; EuroSCORE, European system for cardiac operative risk evaluation; HR, hazard ratio; TAVI, transcatheter aortic valve implantation.
| Parameters . | HR (95% Cl) . | P-value . |
|---|---|---|
| Model 1 | ||
| Euroscore II, per 1% increase | 0.991 (0.948–1.037) | 0.706 |
| Late vs. early TAVI | 0.503 (0.344–0.736) | <0.001 |
| Staging at baseline (per 1 stage increase) | 1.316 (1.097–1.577) | 0.003 |
| Model 2 | ||
| Euroscore II, per 1% increase | 1.033 (0.981–1.089) | 0.218 |
| Late vs. early TAVI | 0.574 (0.336–0.981) | 0.042 |
| Staging at baseline (per 1 stage increase) | 0.948 (0.717–1.254) | 0.710 |
| Staging at 6 months (per 1 stage increase) | 1.368 (1.002–1.867) | 0.048 |
| Model 3 | ||
| Euroscore II, per 1% increase | 1.033 (0.981–1.089) | 0.217 |
| Late vs. early TAVI | 0.581 (0.340–0.994) | 0.047 |
| Staging at baseline (per 1 stage increase) | 1.391 (1.024–1.890) | 0.035 |
| Staging evolution at 6 months | ||
| Improved | — | 0.017 |
| Stabilized | 1.838 (0.993–3.401) | 0.053 |
| Worsened | 3.729 (1.494–9.305) | 0.005 |
| Parameters . | HR (95% Cl) . | P-value . |
|---|---|---|
| Model 1 | ||
| Euroscore II, per 1% increase | 0.991 (0.948–1.037) | 0.706 |
| Late vs. early TAVI | 0.503 (0.344–0.736) | <0.001 |
| Staging at baseline (per 1 stage increase) | 1.316 (1.097–1.577) | 0.003 |
| Model 2 | ||
| Euroscore II, per 1% increase | 1.033 (0.981–1.089) | 0.218 |
| Late vs. early TAVI | 0.574 (0.336–0.981) | 0.042 |
| Staging at baseline (per 1 stage increase) | 0.948 (0.717–1.254) | 0.710 |
| Staging at 6 months (per 1 stage increase) | 1.368 (1.002–1.867) | 0.048 |
| Model 3 | ||
| Euroscore II, per 1% increase | 1.033 (0.981–1.089) | 0.217 |
| Late vs. early TAVI | 0.581 (0.340–0.994) | 0.047 |
| Staging at baseline (per 1 stage increase) | 1.391 (1.024–1.890) | 0.035 |
| Staging evolution at 6 months | ||
| Improved | — | 0.017 |
| Stabilized | 1.838 (0.993–3.401) | 0.053 |
| Worsened | 3.729 (1.494–9.305) | 0.005 |
Values are HR (95% CI). Bold values represent significant P-values (<0.05).
CI, confidence interval; EuroSCORE, European system for cardiac operative risk evaluation; HR, hazard ratio; TAVI, transcatheter aortic valve implantation.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
